These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 16183573)

  • 1. Teratogen risk counselling by internet: a prospective cohort study.
    Han JY; Yang JH; Chung JH; Choi JS; Ahn HK; Ryu HM; Kim MY; Cho SI; Nava-Ocampo AA
    J Obstet Gynaecol; 2005 Jul; 25(5):427-31. PubMed ID: 16183573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The Israel Teratogen Information Service: a report of the last ten years with 20,613 calls].
    Ornoy A; Shechtman S; Arnon J
    Harefuah; 1999 Jan; 136(1):1-9, 96. PubMed ID: 10914148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maternal fever and birth outcome: a prospective study.
    Chambers CD; Johnson KA; Dick LM; Felix RJ; Jones KL
    Teratology; 1998 Dec; 58(6):251-7. PubMed ID: 9894674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pregnancy outcome following exposure to permethrin and use of teratogen information.
    Kennedy D; Hurst V; Konradsdottir E; Einarson A
    Am J Perinatol; 2005 Feb; 22(2):87-90. PubMed ID: 15731987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pregnancy outcome after gestational exposure to metronidazole: a prospective controlled cohort study.
    Diav-Citrin O; Shechtman S; Gotteiner T; Arnon J; Ornoy A
    Teratology; 2001 May; 63(5):186-92. PubMed ID: 11320529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pregnancy outcome after gestational exposure to the new macrolides: a prospective multi-center observational study.
    Bar-Oz B; Diav-Citrin O; Shechtman S; Tellem R; Arnon J; Francetic I; Berkovitch M; Ornoy A
    Eur J Obstet Gynecol Reprod Biol; 2008 Nov; 141(1):31-4. PubMed ID: 18760873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the effectiveness of a teratogen information service: a survey of patient and professional satisfaction.
    Ludowese CJ; Marini T; Laxova R; Pauli RM
    Teratology; 1993 Sep; 48(3):233-45. PubMed ID: 8248861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The safety of cetirizine during pregnancy. A prospective observational cohort study.
    Weber-Schoendorfer C; Schaefer C
    Reprod Toxicol; 2008 Sep; 26(1):19-23. PubMed ID: 18571373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of the Internet by women seeking information about potentially teratogenic agents.
    De Santis M; De Luca C; Quattrocchi T; Visconti D; Cesari E; Mappa I; Nobili E; Spagnuolo T; Caruso A
    Eur J Obstet Gynecol Reprod Biol; 2010 Aug; 151(2):154-7. PubMed ID: 20478650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pregnancy outcome of women inadvertently exposed to ribostamycin during early pregnancy: a prospective cohort study.
    Lee SW; Han JY; Choi JS; Chung JH; Kim MY; Yang JH; Koong MK; Nava-Ocampo AA; Koren G
    Reprod Toxicol; 2009 Apr; 27(2):196-8. PubMed ID: 19162171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pregnancy outcome after in utero exposure to colchicine.
    Diav-Citrin O; Shechtman S; Schwartz V; Avgil-Tsadok M; Finkel-Pekarsky V; Wajnberg R; Arnon J; Berkovitch M; Ornoy A
    Am J Obstet Gynecol; 2010 Aug; 203(2):144.e1-6. PubMed ID: 20579964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Teratological risk evaluation and prevention of voluntary abortion.
    De Santis M; Straface G; Cavaliere AF; Cinque B; Carducci B; Caruso A
    Minerva Ginecol; 2006 Apr; 58(2):91-9. PubMed ID: 16582865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isotretinoin exposure and pregnancy outcome: an observational study of the Berlin Institute for Clinical Teratology and Drug Risk Assessment in Pregnancy.
    Schaefer C; Meister R; Weber-Schoendorfer C
    Arch Gynecol Obstet; 2010 Feb; 281(2):221-7. PubMed ID: 19444462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pregnancy outcome following first-trimester exposure to zopiclone: a prospective controlled cohort study.
    Diav-Citrin O; Okotore B; Lucarelli K; Koren G
    Am J Perinatol; 1999; 16(4):157-60. PubMed ID: 10458526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maternal occupational exposure to solvents and congenital malformations: a prospective study in the general population.
    Garlantézec R; Monfort C; Rouget F; Cordier S
    Occup Environ Med; 2009 Jul; 66(7):456-63. PubMed ID: 19541806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abrupt discontinuation of psychotropic drugs during pregnancy: fear of teratogenic risk and impact of counselling.
    Einarson A; Selby P; Koren G
    J Psychiatry Neurosci; 2001 Jan; 26(1):44-8. PubMed ID: 11212593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human teratogens and evidence-based teratogen risk counseling: the Motherisk approach.
    Nava-Ocampo AA; Koren G
    Clin Obstet Gynecol; 2007 Mar; 50(1):123-31. PubMed ID: 17304029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Assessment of occupational factors of influence on pregnancy].
    Herpel S; Straube E
    Zentralbl Gynakol; 1988; 110(8):516-22. PubMed ID: 3400371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fetal exposure to isotretinoin-an international problem.
    Garcia-Bournissen F; Tsur L; Goldstein LH; Staroselsky A; Avner M; Asrar F; Berkovitch M; Straface G; Koren G; De Santis M
    Reprod Toxicol; 2008 Jan; 25(1):124-8. PubMed ID: 18077132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Post-marketing surveillance system for drugs in pregnancy--15 years experience of ENTIS.
    Schaefer C; Hannemann D; Meister R
    Reprod Toxicol; 2005; 20(3):331-43. PubMed ID: 15978773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.